Next Article in Journal
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice
Next Article in Special Issue
Gut Microbiota and Bile Acids Mediate the Clinical Benefits of YH1 in Male Patients with Type 2 Diabetes Mellitus: A Pilot Observational Study
Previous Article in Journal
Preparation and Study of Solid Lipid Nanoparticles Based on Curcumin, Resveratrol and Capsaicin Containing Linolenic Acid
Previous Article in Special Issue
Resveratrol Inhibited ADAM10 Mediated CXCL16-Cleavage and T-Cells Recruitment to Pancreatic β-Cells in Type 1 Diabetes Mellitus in Mice
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(8), 1594; https://doi.org/10.3390/pharmaceutics14081594
Action Date Notes Link
article pdf uploaded. 30 July 2022 12:15 CEST Version of Record https://www.mdpi.com/1999-4923/14/8/1594/pdf-vor
article supplementary file uploaded. 30 July 2022 12:15 CEST - https://www.mdpi.com/1999-4923/14/8/1594#supplementary
article xml file uploaded 15 August 2022 11:38 CEST Original file -
article xml uploaded. 15 August 2022 11:38 CEST Update -
article pdf uploaded. 15 August 2022 11:38 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1594/pdf-vor
article html file updated 15 August 2022 11:39 CEST Original file -
article xml file uploaded 25 August 2022 05:42 CEST Update -
article xml uploaded. 25 August 2022 05:42 CEST Update https://www.mdpi.com/1999-4923/14/8/1594/xml
article pdf uploaded. 25 August 2022 05:42 CEST Updated version of record https://www.mdpi.com/1999-4923/14/8/1594/pdf
article html file updated 25 August 2022 05:44 CEST Update https://www.mdpi.com/1999-4923/14/8/1594/html
Back to TopTop